Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.51 |
| ▸ | NTSR1 | P30989 | 8/20 | 0.48 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.47 |
| ▸ | CHRND | Q07001 | 6/20 | 0.47 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.47 |
| ▸ | CHRNG | P07510 | 2/20 | 0.47 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.45 |
| ▸ | NPY2R | P49146 | 1/20 | 0.45 |
| ▸ | NPY4R | P50391 | 1/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL306050 | 0.91 | FOLH1 (0.50) | NTSR1CHRNDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL19211966 | 0.90 | FOLH1 (0.49) | NTSR1CHRNDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL9318080 | 0.90 | SLC15A2 (0.60) | SLC15A2ERAP2LNPEPCHRNDCHRNA1 | |
| SCHEMBL9318061 | 0.90 | SLC15A2 (0.60) | SLC15A2ERAP2LNPEPCHRNDCHRNA1 | |
| SCHEMBL7122844 | 0.89 | SLC15A2 (0.59) | SLC15A2ERAP2LNPEPCHRNDCHRNA1 | |
| SCHEMBL7122854 | 0.89 | SLC15A2 (0.59) | SLC15A2ERAP2LNPEPCHRNDCHRNA1 | |
| SCHEMBL29980121 | 0.86 | SLC15A2 (0.54) | SLC15A2ERAP2LNPEPCHRNDCHRNA1 | |
| SCHEMBL9715437 | 0.85 | CHRND (0.44) | LNPEPCHRNDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL29630584 | 0.83 | CHRND (0.53) | SLC15A2ERAP2LNPEPCHRNDCHRNA1 | |
| SCHEMBL18064482 | 0.83 | CHRND (0.40) | NTSR1ERAP2LNPEPCHRNDCHRNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0353295-B1 | NOVEL AND IMPROVED ANTIBODIES FOR SITE SPECIFIC ATTACHMENT OF COMPOUNDS | CYTOGEN CORP (US) | 1994-04-06 | — | — | EP | claimed |
| EP-0173629-B1 | ANTIBODY-METAL ION COMPLEXES | CYTOGEN CORPORATION (US) | 1992-06-10 | — | — | EP | claimed |
| EP-0382796-A4 | METHOD FOR THE PREPARATION OF ANTIBODY-FRAGMENT CONJUGATES | — | 1991-08-28 | — | — | EP | claimed |
| EP-0382796-A1 | METHOD FOR THE PREPARATION OF ANTIBODY-FRAGMENT CONJUGATES | CYTOGEN CORPORATION (US) | 1990-08-22 | — | — | EP | claimed |
| US-4937183-A | Therapy, diagnostis immunology | CYTOGEN CORPORATION (US) | 1990-06-26 | — | — | US | claimed |
| WO-1989007269-A1 | METHOD FOR THE PREPARATION OF ANTIBODY-FRAGMENT CONJUGATES | CYTOGEN CORPORATION (US) | 1989-08-10 | — | — | WO | claimed |
| US-4741900-A | Antibody-metal ion complexes | CYTOGEN CORPORATION (US) | 1988-05-03 | — | — | US | claimed |
| WO-1986001410-A1 | ANTIBODY-METAL ION COMPLEXES | CYTOGEN CORPORATION (US) | 1986-03-13 | — | — | WO | claimed |
| EP-0173629-A1 | Antibody-metal ion complexes | CYTOGEN CORPORATION (US) | 1986-03-05 | — | — | EP | claimed |
| EP-0173629-B1 | ANTIBODY-METAL ION COMPLEXES | CYTOGEN CORPORATION (US) | 1992-06-10 | — | — | EP | disclosed |
| US-4741900-A | Antibody-metal ion complexes | CYTOGEN CORPORATION (US) | 1988-05-03 | — | — | US | disclosed |
| EP-0173629-A1 | Antibody-metal ion complexes | CYTOGEN CORPORATION (US) | 1986-03-05 | — | — | EP | disclosed |